International Alliance for Personalised Medicine (IAPM) shared on LinkedIn:
“IPM Brief – Issue 16 is now available
Scientific breakthroughs make headlines. But headlines alone do not improve patient outcomes.ch
The latest edition of the IPM Brief explores what happens after the announcement – when innovation meets the realities of healthcare systems, regulation, reimbursement and implementation.
This week’s issue looks at:
- AI-generated vaccines and the governance questions they raise
- The future of pharmaceutical manufacturing and global supply chains
- Medical tourism and increasingly connected healthcare systems
- Lung cancer screening and the importance of implementation pathways
- Clinical trials, drug development and the need for better patient stratification
- Health policy reforms that ask a fundamental question: are we building stronger pathways to care, or simply creating new barriers?
At IAPM, we believe that the true measure of innovation is not how quickly discoveries are made, but how effectively they reach patients.
Every edition of the IPM Brief goes beyond reporting the news. We connect science, policy and implementation to explain what developments mean for healthcare systems, clinicians, policymakers – and, most importantly, patients.
Issue 16 is now available.
Not yet subscribed? Join our growing community and receive the IPM Brief directly in your inbox twice every week.
Evidence-based. Globally focused. Patient-centred.”
You can also find this interesting:
FDA Announces 3 Final Guidances to Increase Patient Participation in Oncology Trials
